PDG11- HEALTH AND ECONOMIC OUTCOMES OF A NEW ORAL DIABETES DRUG, PIOGLITAZONE (ACTOSNF, TAKEDA), IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN NORWAY
Sep 1, 2001, 00:00
10.1016/S1098-3015(11)71748-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)71748-X/fulltext
Title :
PDG11- HEALTH AND ECONOMIC OUTCOMES OF A NEW ORAL DIABETES DRUG, PIOGLITAZONE (ACTOSNF, TAKEDA), IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN NORWAY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71748-X&doi=10.1016/S1098-3015(11)71748-X
First page :
Section Title :
Open access? :
No
Section Order :
262